History of avermectin and Ivermectin, with notes on the history of other macrocyclic lactone antiparasitic agents

Current Pharmaceutical Biotechnology

Volumn 13, Issue 6, 2012, Pages 853-865

  Campbell, William C ^a  

^a DREW UNIVERSITY   (United States)

Author keywords

Antiparasitics; Avermectin; Endecticides; History; Ivermectin; Macrocyclic lactones

Indexed keywords

ABAMECTIN; AVERMECTIN; DORAMECTIN; EPRINOMECTIN; IVERMECTIN; MILBEMYCIN; MOXIDECTIN; NEMADECTIN; SELAMECTIN; TIABENDAZOLE;

ACTINOBACTERIA; ANIMAL HEALTH; ANIMAL HUSBANDRY; ANTHELMINTIC ACTIVITY; ARTHROPOD; DRUG SAFETY; ENTOMOPATHOGENIC NEMATODE; FILARIA; NONHUMAN; ONCHOCERCA; ONCHOCERCIASIS; REVIEW; WORLD HEALTH ORGANIZATION;

ANIMALIA; ARTHROPODA; BACTERIA (MICROORGANISMS); NEMATODA;

EID: 84860539108     PISSN: 13892010     EISSN: 18734316     Source Type: Journal    
DOI: 10.2174/138920112800399095     Document Type: Review

References (80)

1. Burg, R.W. Trends in the use of fermentation products in agriculture. In: American Chemical Society Symposium Series; Moats, W.A., Ed.; No. 320. 1986, pp. 61-72.
2. Campbell, W.C. The genesis of the antiparasitic drug ivermectin. In: Inventive Minds, Weber, R.J.; Perkins, D.N., Eds.; Oxford University Press: New York, 1992, pp. 194-214.
3. Campbell, W.C. Too much of a good thing. Chem. Eng. News, 1993, March 8.
4. Campbell, W. C. Serendipity and new drugs for infectious diseases. ILAR J., 2005, 46(4), 352-356.
5. Campbell, W.C.; Fisher; M.H.; Stapley, E.O.; Albers-Schonberg G.; Jacobs, T.A. Ivermectin: a potent new antiparasitic agent. Science, 1983, 221(4613), 823-828.
6. Campbell, W.C.; Burg, R.W.; Fisher, M.H.; Dybas, R.A. The discovery of ivermectin and other avermectins. In: Pesticide Synthesis Through Rational Approaches, ACS Symposium Series 255. Magee, P.S. Ed.; Washington DC. 1984, pp. 1-20.
7. Crump, A.; Otogura, K. Omura, S. In pursuit of nature's bounty. Trends Parasitol., 2005, 21(3), 126-132.
8. Esch, G.W. The discovery of ivermectin: a 'crapshoot', or not. In: Parasites and Infectious Disease. Cambridge University Press: Cambridge, U.K. 2007, pp.175-187.
9. Geary, T.G. Ivermectin 20 years on: maturation of a wonder drug. Trends Parasitol., 2005, 21(11), 530-532.
10. Omura S.; Crump, A. The life and times of ivermectin-a success story. Nature Rev., 2004, 2(12), 984-989.
11. Omura S. Letter to Editor. C&EN, 2005; September 12.
12. Omura, S. Ivermectin: 25 years and still going strong. Intl. J. Antimicrob. Agents, 2008, 31(2), 91-98.
13. Shoop W.L.; Mrozik, H.; Fisher, M.H. Structure and activity of avermectins and milbemycins. Vet. Parasitol., 1995, 59, 139-156.
14. Shoop W.L.; Soll, M.D. Ivermectin, abamectin and eprinomectin. In: Macrocyclic Lactones in Antiparasitic Therapy; Vercruysse, J.; Rew, R.S., Eds.; CABI Publishing: Wallingford, UK 2002; pp. 1-29.
15. Stapley, E.O.; Woodruff, H.B. Avermectins, antiparasitic lactones produced by Streptomyces avermitilis isolated from a soil in Japan. In: Trends Antibiot. Res.; Umezawa, H.; Demain, A. L.; Hata, T.; Hutchinson, C.R., Eds.; Japan Antibiotics Research Association: Tokyo, 1982; pp.154-170.
16. Strohl, W.R.; Woodruff, H.B.; Monaghan, R.L.; Hendlin, D.; Mochales, S.; Demain, A.L.; Liesch, J. The history of natural product research at Merck & Co., Inc. SIM News 2001, 51(1), 5-19.
17. Vagelos, P.R. The Moral Compass: Merck Experiences; Cambridge University Press: New York, 2006
18. Woodruff, H.B. A soil microbiologist's odyssey. Ann. Rev. Microbiol., 1981, 35, 1-28.
19. Woodruff, H. B. Fifty year's experience with actinomycete ecology. Actinomycetology, 1989, 3(2), 79-88.
20. Brown, H.D.; Matzuk; A.R.; Ilves, I.R.; Peterson, L.H.; Harris, S.A.; Sarett, L.H.; Egerton, J.R.; Yakstis, J.J.; Campbell, W.C.; Cuckler, A.C. Antiparasitic drugs. IV. 2-(4 'thiazolyl)-benzimidazole, a new anthelmintic. J. Am. Chem. Soc., 1961, 83(7), 1764-1765.
21. Burg R.W.; Miller B.M.; Baker E.E.; Birnbaum J.; Currie S.A.; Hartman R.; Kong, Y.; Monaghan, R.L.; Olson, G.; Putter, I.; Tunac, J.B.; Hallick, H.; Stapley, E.O.; Ruiko O.; Omura S. Avermectins, new family of potent anthelmintic agents: producing organism and fermentation. Antimicrob. Agents Chemotherap., 1979, 15(3), 361-367.
22. Burg, R.W.; Stapley, E.O. Isolation and characterization of the producing organism. In: Ivermectin and abamectin; Campbell, W.C., Ed.; Springer-Verlag: New York, 1989, pp. 24-32.
23. 1b by liver microsomes. Drug Metab. Dispot., 1982, 10(3), 268-274.
24. Ikeda, H.; Ishikawa, J.; Hanamoto A.; Shinose, M; Kikuchi, H.; Shiba, T.; Sakaki, Y.; Hattori M.; Omura S. Complete genome sequence and comparative analysis of the industrial microorganism Streptomyces avermitilis. Nat. Biotechnol., 2003, 21, 526-531.
25. Takahashi, Y.; Matsumoto, A.; Seino, A.; Ueno, J.; Iwai, Y.; Omura, S. Streptomyces avermectinius sp. no., an avermectin-producing strain. Int. J. Systt. Evol. Microbiol., 2002, 52(6), 2163-2168.
26. Omura, S.; Ikeda, H.; Ishikawa, J.; Hanamoto, A.; Takahashi, C.; Shinose, M.; Takahashi, Y.; Horikawa, H.; Nakazawa, H.; Osonoe, T.; Kikuchi, H.; Shiba, T.; Sakaki, Y.; Hattori, M. Genome sequence of an industrial microorganism Streptomyces avermitilis: deducing the ability of producing secondary metabolites. PNAS, 2001. 98(21), 12215-12220.
27. Sarett, L.H.; Roche, C.; Tishler, M. Biographical memoirs. National Academy of Sciences, National Academies Press, 1995, 66, 352-366.
28. Miller, T.W.; Chaiet, L.; Cole, D.J.; Cole, L.J.; Flor, J.E.; Goegelman, R.T.; Gullo, V.P.; Joshua, H.; Kempf, A.J.; Krellwitz, W.R.; Monaghan, R.L.; Ormond, R.E.; Wilson, K.E.; Albers-Schonberg, G.; Putter, I. Avermectins, a new family of potent anthelmintic agents: isolation and chromatographic properties. Antimicrob. Agents Chemotherap., 1979, 15(3), 638-371.
29. Albers-Schonberg, G.; Arison, B.H.; Chabala, J.C.; Douglas, A.W.; Eskola, P.; Fisher, M.H.; Lusi, A.; Mrozik, H.; Smith, J.L.; Tolman, RL. Avermectins. Structure determination. J. Am. Chem. Soc., 1981, 103(14), 4216-4221.
30. Jung, M.; Saito, A.; Buescher, G.; Maurer, M.; Graf, J.F. Chemistry, pharmacology and safety: milbemycin oxime. In: Macrocyclic Lactones in Antiparasitic Therapy; Vercruysse, J.; Rew, R.S.; Eds.; CABI Publishing: Wallingford, UK. 2002; 5pp. 1-74.
31. Chabala, J.C.; Mrozik, H.; Tolman, R.L.; Eskola, P.; Lusi, A.; Peterson, L.H.; Woods, M.F.; Fisher, M.H.; Campbell, W.C.; Egerton, J.R.; Ostlind, D.A. Ivermectin, a new broad-spectrum antiparasitic agent. J. Med. Chem., 1980, 2(11), 1134-1136.
32. Fisher, M.H.; Mrozik, H. Chemistry. In: Ivermectin and Abamectin; Campbell, W.C., Ed.; Springer-Verlag: New York, 1989; pp. 1-23.
33. Fisher, M.H.; Mrozik, H. The avermectin family of macrolide-like antibiotics. In: Macrolide Antibiotics; Omura, S., Ed.; Academic Press: New York, 1984; pp. 553-606.
34. Turner and Schaeffer, Mode of action of ivermectin. In: Ivermectin and Abamectin. Campbell, W.C., Ed.; Springer-Verlag: New York, 1989; pp. 73-88.
35. Martin R.J.; Robertson, A.P.; Wolstenholme, A.J. Mode of action of the macrocyclic lactones. In: Macrocyclic Lactones in Antiparasitic Therapy (Vercruysse J. and Rew, R.S., Eds.). CABI Publishing: Wallingford, UK. 2002; pp.125-140.
36. Halley, B.A.; Nessel, R.J.; Lu, A.Y.H. Environmental aspects of ivermectin usage in livestock: general considerations. In: Ivermectin and Abamectin; Campbell, W. C., Ed.;Springer-Verlag: New York, 1989; pp. 162-172.
37. Roncalli, R.A. Environmental aspects of use of ivermectin and abamectin in livestock: effects on cattle dung fauna. In: Ivermectin and abamectin; Campbell, W.C.; Ed.; Springer-Verlag: New York, 1989; pp. 173-181.
38. Steel, J.W.; Wardhaugh, K.G. Ecological impact of macrocyclic lactones on dung fauna. In: Macrocyclic Lactones in Antiparasitic Therapy Vercruysse, J.; Rew, R. S.; Eds.; CABI Publishing; Wallingford, UK. 2002; pp. 141-162.
39. Dybas, R.A. Abamectin use in crop protection. In: Ivermectin and Abamectin; Campbell, W.C. Ed.; Springer-Verlag; New York, 1989; pp. 287-310.
40. Soll, M.D. Use of ivermectin in laboratory and exotic mammals and in birds, fish and reptiles. In: Ivermectin and Abamectin; Campbell, W.C. Ed.; Springer-Verlag: New York, 1989; pp. 260-286.
41. Little, S.E.; Greenacre, C.B.; Kaplan, R.M. The use of macrocyclic lactones to control parasites of exotic pests. In: Macrocyclic Lactones in Antiparasitic Therapy; Vercruysse, J.; Rew, R. S.; Eds.; CABI Publishing, Wallingford, UK. 2002; pp. 395-403.
42. Marley, S.E.; Conder, G.A. The use of macrocyclic lactones to control parasites of domesticated wild ruminants. In: Macrocyclic Lactones in Antiparasitic Therapy; Vercruysse, J.; Rew, R. S.; Eds.; CABI Publishing: Wallingford, UK. 2002; pp. 71-393.
43. Di Netta, J. List of Registrations. In: Ivermectin and Abamectin; Campbell, W.C. Ed.; Springer-Verlag: New York, 1989; pp. 344-346.
44. Egerton, J.R.; Eary, C.H.; Suhayda, D. Dose-titration studies of ivermectin against experimental Ancylostoma caninum and Uncinaria stenocephala infections. Am. J. Vet. Res., 1985, 46(5), 1057-1059.
45. Brown, K.R. The use of macrocyclic lactones to control parasites of humans. In: Macrocyclic Lactones in Antiparasitic Therapy; Vercruysse, J.; Rew, R. S.; Eds.; CABI Publishing: Wallingford, UK. 2002, pp. 405-412.
46. 1) against adult Setaria equina and microfilariae of Onchocerca cervicalis in ponies. J. Parasitol., 1980, 66(5), 859-861
47. Egerton, J. R,; Brokken, E.S.; Suhayda, D.; Eary, C.H.; Wooden, J. W.; Kilgore, R.I. The antiparasitic activity of ivermectin in horses. Vet. Parasitol. 1981, 8, 83-88.
48. Aziz, M.A.; Diallo, S.; Diop, I.M.; Larivière, M.; Porta, M. Efficacy and tolerance of ivermectin in human onchocerciasis., Lancet, 1982, 2(8291), 171-173.
49. Larivière, M.; Aziz, M.A.; Diallo, S.; Diop-Mar, I.; Porta, M. Efficacité et tolérance de l'ivermectine (MK 933) dans l'onchocercose humaine. Journ. Hosp. Claude Bernard, 1982, 227-233.
50. Rougemont, A. Ivermectin for onchocerciasis. Lancet, 1982, 1158.
51. Aziz, M.A.; Diallo, S.; Diop, I.M.; Larivière, M.; Porta, M. Efficacy and tolerance of ivermectin in human onchocerciasis. Lancet, 1982, 2, 1456-1457.
52. Campbell, W. C. Ivermectin as an antiparasitic agent for use in humans. Annu. Rev. Microbiol., 1991, 45, 445-474.
53. Greene, B.M.; Brown, K.R.; Taylor, H.R. Use of ivermectin in humans. In: Ivermectin and Abamectin; Campbell, W.C. Ed.; Springer-Verlag; New York, 1989; pp. 311-323.
54. Ottesen, E.A.; Campbell W.C. Ivermectin in human medicine. J. Antimicrob. Chemotherap., 1994, 34(2), 195-203.
55. Elkholm, E. Conquering an ancient scourge. New York Times Magazine, 1989, January 8, 20-59.
56. Useem, M. Roy Vagelos attacks river blindness. In: The Leadership Moment; Times Books, Random House Inc.: New York N.Y., 1998; pp.10-42.
57. Collins K. Profitable gifts: a history of the Merck Mectizan® donation program and its implications for international health. Perspect. Biol. Med., 2004, 47(1), 100-109.
58. Colatrella, B. The Mectizan Donation Program: 20 years of successful collaboration-a retrospective. Ann. Trop. Med. Parasitol., 2008, 102(Suppl.1), 7-11.
59. Brown, K.R.; Ricci, F.M.; Ottesen, E.A. Ivermectin: effectiveness in lymphatic filariasis. Parasitol., 2000, S121, 133-146.
60. Campbell, W.C.; Blair, L.S.; McCall, J.W. Brugia pahangi and Dirofilaria immitis: experimental infections in the ferret, Mustela putorius furo. Exp. Parasitol., 1979, 47(3), 327-332.
61. Campbell, W.C.; Blair, L.S. Dirofilaria immitis: experimental infections in the ferret (Mustela putorius furo). J. Parasitol., 1978, 64(1) 119-122.
62. Blair, L.S.; Campbell, W.C. Efficacy of avermectins against Ancylostoma caninum in dogs. J. Helminthol., 1978, 52, 305-307.
63. 1a against microfilariae of Dirofilaria immitis. Am. J. Vet. Res., 1979, 40(7), 1031-1032.
64. Campbell, W.C.; Blair, L.S. Efficacy of avermectins against Dirofilaria immitis in dogs. J. Helminthol., 1978, 52, 308-310.
65. 1, a new broad-spectrum antiparasitic agent. Br. Vet. J., 1980, 136(1), 88-97.
66. McCall J.W.; Lindemann B.E.; Porter C.A. In: Proceedings of the Heartworm Symposium 1981; Otto G.F. Ed.; Veterinary Medicine Publishing Co.: Edwardsville KS. 1981; pp.126-130.
67. Jackson R.F.; Seymour W.G. In: Proceedings of the Heartworm symposium, 1980; Otto G.F., Ed.; Veterinary Medicine Publishing Co.: Edwardsville, Kansas, 1981; pp.131-136.
68. Campbell, W.C. Ivermectin and heartworm. Semin. Vet. Med. Surg. (Small Anim.), 1987, 2(1), 48-55.
69. Blair, L.S.; Campbell, W.C. Efficacy of ivermectin against Dirofilaria immitis larvae in dogs at 31, 60 and 90 days after infection. Am. J. Vet. Res., 1980, 41(12), 2108.
70. Soll, M.D.; Plue, R.E.; Alva, R.A.; Fulton, R.K.; Seward, R.L.; Daurio, C. P, Cifelli, C.S. Field safety, efficacy and acceptability of ivermectin in a chewable form for dogs. Can. Pract., 1991, 16, 5-8.
71. Vercruysse, J.; Rew, R.S. Macrocyclic Lactones in Antiparasitic Therapy. CABI Publishing: Wallingford, UK, 2002.
72. Dutton, C.J.; Gibson, S.P.; Goudie, A.C.; Holdom, K.S.; Pacey, M.S.; Ruddock, J.C.; Bulock, J.D.; Richards, M.K. Novel avermectins produced by mutational biosynthesis. J. Antibiot., 1991, 44(3), 357-365
73. Conder, G.A.; Baker, W.J. Chemistry, pharmacology and safety: doramectin and selamectin. In: Macrocyclic Lactones in Antiparasitic Therapy; Vercruysse J.; Rew, R.S., Eds.; CABI Publishing: Wallingford, UK. 2002; pp. 30-50.
74. Bishop, B.F.; Bruce, C.I.; Evans, N.A.; Goudie, A.C.; Gration, K.F.; Gibson, S.P.; Pacey, M.S.; Perry, D.A.; Walshe, N.D.A.; Witty, M.J. Selamectin: a novel broad-spectrum endectocide for dogs and cats. Vet. Parasitol., 2000, 91(3), 163-176.
75. Rock, D.W.; DeLay, R.L.; Gliddon, M.J. Chemistry, pharmacology and safety: moxidectin. In: Macrocyclic Lactones in Antiparasitic Therapy; Vercruysse J.; Rew, R.S., Eds.; CABI Publishing; Wallingford, UK. 2002; pp. 75-96.
76. Shoop, W.L. Eprinomectin: a novel avermectin for use as a topical endecticide for cattle. Int. J. Parasitol., 1996, 26(11), 1227-1235.
77. Foege, H.W. 10 years of Mectizan. Ann. Trop. Med. Parasitol., 1998, 92(Suppl.1), 7-10.
78. Thylefors, B.; Lawrence, J. Twenty years of Mectizan mass treatment: past, present and future perspectives. Ann. Trop. Med. Parasitol., 2008, 102(Suppl.1), 1-45.
79. Thylefors, B. The Mectizan Donation Program (MDP). Ann. Trop. Med. Parasitol., 2008, 102(Suppl.1), 39-44
80. WHO. Tropical Diseases Today-The Challenge and the Opportunity, World Health Organization, Geneva, Switzerland, 1975.